Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol

2005 ◽  
Vol 38 (5) ◽  
pp. 803-807 ◽  
Author(s):  
L DALLALIBERA ◽  
B RAVARA ◽  
V GOBBO ◽  
D BETTO ◽  
E GERMINARIO ◽  
...  
2007 ◽  
Vol 103 (3) ◽  
pp. 285-290 ◽  
Author(s):  
Giorgio Vescovo ◽  
Barbara Ravara ◽  
Luciano Dalla Libera

2005 ◽  
Vol 289 (4) ◽  
pp. H1512-H1518 ◽  
Author(s):  
Jennifer G. Duncan ◽  
Rajashree Ravi ◽  
Linda B. Stull ◽  
Anne M. Murphy

Heart failure is a clinical syndrome associated with elevated levels of oxygen-derived free radicals. Xanthine oxidase activity is believed to be one source of reactive oxygen species in the failing heart. Interventions designed to reduce oxidative stress are believed to have significant therapeutic potential in heart failure. This study tested the hypothesis that xanthine oxidase activity would be elevated in a mouse model of dilated cardiomyopathy and evaluated the effect of chronic oral allopurinol, an inhibitor of xanthine oxidase, on contractility and progressive ventricular dilation in these mice. Nontransgenic and transgenic mice containing a troponin I truncation were treated with oral allopurinol from 2–4 mo of age. Myocardial xanthine oxidase activity was threefold higher in untreated transgenic mice compared with nontransgenic mice. Analyses of myofilament proteins for modification of carbonyl groups demonstrated myofibrillar protein damage in untreated transgenic mice. Treatment with allopurinol for 2 mo suppressed xanthine oxidase activity and myofibrillar protein oxidation. Allopurinol treatment also alleviated ventricular dilation and preserved shortening fraction in the transgenic animals. In addition, cardiac muscle twitch tension was preserved to 70% of nontransgenic levels in allopurinol-treated transgenic mice, a significant improvement over untreated transgenic mice. These findings indicate that chronic inhibition of xanthine oxidase can alter the progression of heart failure in dilated cardiomyopathy.


2005 ◽  
Vol 288 (4) ◽  
pp. E685-E692 ◽  
Author(s):  
Michael J. Toth ◽  
Dwight E. Matthews ◽  
Philp A. Ades ◽  
Marc D. Tischler ◽  
Peter Van Buren ◽  
...  

Chronic heart failure is characterized by changes in skeletal muscle that contribute to physical disability. Most studies to date have investigated defects in skeletal muscle oxidative capacity. In contrast, less is known about how heart failure affects myofibrillar protein metabolism. Thus we examined the effect of heart failure on skeletal muscle myofibrillar protein metabolism, with a specific emphasis on changes in myosin heavy chain (MHC) protein content, synthesis, and isoform distribution in 10 patients with heart failure (63 ± 3 yr) and 11 controls (70 ± 3 yr). In addition, we examined the relationship of MHC protein metabolism to inflammatory markers and physical function. Although MHC and actin protein content did not differ between groups, MHC protein content decreased with increasing disease severity in heart failure patients ( r = −0.748, P < 0.02), whereas actin protein content was not related to disease severity. No difference in MHC protein synthesis was found between groups, and MHC protein synthesis rates were not related to disease severity. There were, however, relationships between C-reactive protein and both MHC protein synthesis ( r = −0.442, P = 0.05) and the ratio of MHC to mixed muscle protein synthesis ( r = −0.493, P < 0.03). Heart failure patients showed reduced relative amounts of MHC I ( P < 0.05) and a trend toward increased MHC IIx ( P = 0.06). In regression analyses, decreased MHC protein content was related to decreased exercise capacity and muscle strength in heart failure patients. Our results demonstrate that heart failure affects both the quantity and isoform distribution of skeletal muscle MHC protein. The fact that MHC protein content was related to both exercise capacity and muscle strength further suggests that quantitative alterations in MHC protein may have functional significance.


Author(s):  
Giorgio Vescovo ◽  
Barbara Ravara ◽  
Daniela Danieli ◽  
Annalisa Angelini ◽  
Luciano Dalla Libera

2007 ◽  
Vol 42 (6) ◽  
pp. S155
Author(s):  
Giorgio Vescovo ◽  
Barbara Ravara ◽  
Daniela Danieli ◽  
Annalisa Angelini ◽  
Luciano Dalla Libera

Sign in / Sign up

Export Citation Format

Share Document